Speaking Engagement: DIA Annual Meeting

Kinetiq Vice President of Client Services, James Riddle, and Regulatory Attorney, Aarthi Iyer, will speak at the upcoming 2017 DIA Annual Meeting in Chicago, IL. James will co-present his session about the revised Common Rule and its impact on research going forward. Aarthi’s session will cover considerations for effective execution and compliance of post-marketing research.


About the Speakers

James Riddle, MCSE, CIP, CPIA brings nearly 20 years’ experience in Human Research Protections leadership. Before joining Kinetiq, James occupied operations leadership roles at both a major independent IRB and a large resesarch organization. James has served on the board of the Northwest Association for Biomedical Research (NWABR) and as an AAHRPP site visitor. In addition to serving on the editorial board of the journal IRB Advisor and on the ACRES Committee on Accreditation, he is a current faculty member, mentor, and regular speaker for Public Responsibility in Medicine and Research (PRIM&R) and other industry conferences.

Aarthi Iyer, JD, MPH, previously worked in the health services research sector for major institutions and initiatives, including Harvard Pilgrim Healthcare and the FDA Sentinel System. Aarthi provides regulatory guidance related to human subject protections. She has in-depth experience in the ethical review of clinical trials and public health activities and is a frequent speaker and author on health care research topics.


About the Conference

DIA, founded as the Drug Information Association, provides a global, neutral forum where stakeholders can openly and freely exchange knowledgeable information and insights beyond boundaries to advance innovation in health care product development and life cycle management globally. The Global Annual Meeting is the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies.